Align Technology Inc
Research Align Technology Inc (ALGN) on Bullrun: valuation model: 1.5% overvalued, market cap USD 11.37B, P/E 27.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALGN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal1.5% overvalued
- Market capUSD 11.37B
- P/E27.7
- Financial periodQ2 2026
- RevenueUSD 1.06B
- Net incomeUSD 108.29M
- Free cash flowUSD 157.09M
- Gross margin71.7%
Valuation Snapshot
Bullrun's latest valuation model marks Align Technology Inc as 1.5% overvalued; latest market cap is USD 11.37B; P/E is 27.7.
Peer valuation comparison
Latest P/E is 27.69x versus a Healthcare sector median of 24.46x (13.2% above).
Latest P/E is 27.69x versus a United States median of 24.87x (11.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 4.03B | USD 410.00M | USD 490.78M | 67.2% | 5.65 | USD 1.09B | USD 114.45M | USD 4.05B |
| FY2024 | USD 4.00B | USD 421.00M | USD 622.65M | 70.0% | 5.62 | USD 1.04B | USD 119.28M | USD 3.85B |
| FY2023 | USD 3.86B | USD 445.00M | USD 608.06M | 70.1% | 5.81 | USD 937.44M | USD 126.62M | USD 3.63B |
| FY2022 | USD 3.73B | USD 362.00M | USD 276.83M | 70.5% | 4.61 | USD 942.05M | USD 96.69M | USD 3.60B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 11.37B | 27.7 | n/a | n/a |
| 2025 | 2025-12-31 | USD 11.14B | 27.6 | n/a | n/a |
| 2024 | 2024-12-31 | USD 15.40B | 37.1 | n/a | n/a |
| 2023 | 2023-12-29 | USD 20.99B | 58.2 | n/a | n/a |
| 2022 | 2022-12-30 | USD 16.47B | 32.6 | n/a | n/a |
| 2021 | 2021-12-31 | USD 51.73B | 67.8 | n/a | n/a |
About Align Technology Inc
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Align Technology Inc overvalued or undervalued?
Bullrun's valuation model currently marks Align Technology Inc as 1.5% overvalued.
What is Align Technology Inc's market cap?
Align Technology Inc's market capitalization is USD 11.37B.
What is Align Technology Inc's P/E ratio?
Align Technology Inc's price-to-earnings (P/E) ratio is 27.7.
What does Align Technology Inc do?
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth.